US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist

2.930
-0.020-0.68%

Trading Apr 16 14:43 ET

440.46MMarket Cap-3662P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

17.99%127.04M

14.00%34.23M

18.36%31.43M

14.95%31.76M

26.25%29.62M

24.70%107.67M

45.38%30.03M

14.32%26.56M

23.11%27.63M

17.18%23.46M

Operating revenue

17.99%127.04M

14.00%34.23M

18.36%31.43M

14.95%31.76M

26.25%29.62M

24.70%107.67M

45.38%30.03M

14.32%26.56M

23.11%27.63M

17.18%23.46M

Cost of revenue

18.64%65.11M

-21.72%9.89M

23.72%18.21M

24.62%20.16M

48.43%16.85M

19.24%54.87M

15.41%12.63M

29.65%14.72M

11.38%16.18M

23.33%11.36M

Gross profit

17.31%61.94M

39.92%24.35M

11.71%13.23M

1.30%11.6M

5.45%12.76M

30.93%52.8M

79.13%17.4M

-0.33%11.84M

44.62%11.46M

11.94%12.1M

Operating expense

-24.14%172.55M

-8.44%34.57M

-28.98%38.16M

-11.40%54.01M

-38.92%45.82M

-11.89%227.46M

-40.31%37.76M

-15.51%53.72M

-10.87%60.95M

19.23%75.03M

Selling and administrative expenses

-2.75%116.66M

-11.54%23.62M

-12.71%24.6M

13.44%36.44M

-2.88%32.01M

-5.80%119.95M

-22.33%26.7M

-19.48%28.18M

-3.13%32.12M

32.83%32.96M

-Selling and marketing expense

-18.02%67.64M

-30.64%12.33M

-29.50%12.96M

-7.56%21.21M

-9.68%21.15M

-5.35%82.51M

-27.41%17.78M

-27.09%18.38M

3.09%22.94M

53.73%23.42M

-General and administrative expense

30.92%49.01M

26.51%11.29M

18.80%11.64M

65.89%15.23M

13.85%10.85M

-6.76%37.44M

-9.74%8.92M

0.13%9.8M

-15.82%9.18M

-0.42%9.53M

Research and development costs

-48.01%55.9M

-0.97%10.95M

-46.93%13.56M

-39.06%17.57M

-67.16%13.82M

-17.82%107.51M

-61.71%11.06M

-10.67%25.55M

-18.16%28.83M

10.37%42.07M

Operating profit

36.67%-110.62M

49.79%-10.22M

40.48%-24.93M

14.33%-42.4M

47.45%-33.06M

19.82%-174.66M

61.98%-20.36M

19.00%-41.88M

18.14%-49.5M

-20.74%-62.92M

Net non-operating interest income expense

39.71%-504K

57.71%-836K

Non-operating interest income

105.37%3.36M

----

278.29%1.64M

----

Non-operating interest expense

56.35%3.87M

----

2.66%2.47M

----

Other net income (expense)

108.58%560K

-203.85%-79K

105.01%344K

130.57%295K

-643.74%-6.53M

52.30%1.32M

96.29%-26K

-1,156.59%-6.86M

-93.00%-965K

Other non- operating income (expenses)

108.58%560K

--0

-203.85%-79K

105.01%344K

130.57%295K

-643.74%-6.53M

52.30%1.32M

96.29%-26K

-1,156.59%-6.86M

-93.00%-965K

Income before tax

39.26%-110.56M

46.03%-10.72M

40.33%-25.01M

25.37%-42.06M

48.71%-32.77M

17.52%-182.02M

63.64%-19.87M

20.04%-41.91M

7.63%-56.36M

-21.43%-63.89M

Income tax

Net income

39.26%-110.56M

46.03%-10.72M

40.33%-25.01M

25.37%-42.06M

48.71%-32.77M

17.52%-182.02M

63.64%-19.87M

20.04%-41.91M

7.63%-56.36M

-21.43%-63.89M

Net income continuous Operations

39.26%-110.56M

46.03%-10.72M

40.33%-25.01M

25.37%-42.06M

48.71%-32.77M

17.52%-182.02M

63.64%-19.87M

20.04%-41.91M

7.63%-56.36M

-21.43%-63.89M

Minority interest income

Net income attributable to the parent company

39.26%-110.56M

46.03%-10.72M

40.33%-25.01M

25.37%-42.06M

48.71%-32.77M

17.52%-182.02M

63.64%-19.87M

20.04%-41.91M

7.63%-56.36M

-21.43%-63.89M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

39.26%-110.56M

46.03%-10.72M

40.33%-25.01M

25.37%-42.06M

48.71%-32.77M

17.52%-182.02M

63.64%-19.87M

20.04%-41.91M

7.63%-56.36M

-21.43%-63.89M

Basic earnings per share

52.10%-0.8

70.59%-0.05

55.26%-0.17

36.36%-0.35

57.14%-0.27

25.45%-1.67

68.52%-0.17

25.49%-0.38

11.29%-0.55

-8.62%-0.63

Diluted earnings per share

52.10%-0.8

70.59%-0.05

55.26%-0.17

36.36%-0.35

57.14%-0.27

25.45%-1.67

68.52%-0.17

25.49%-0.38

11.29%-0.55

-8.62%-0.63

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	17.99%127.04M	14.00%34.23M	18.36%31.43M	14.95%31.76M	26.25%29.62M	24.70%107.67M	45.38%30.03M	14.32%26.56M	23.11%27.63M	17.18%23.46M
Operating revenue	17.99%127.04M	14.00%34.23M	18.36%31.43M	14.95%31.76M	26.25%29.62M	24.70%107.67M	45.38%30.03M	14.32%26.56M	23.11%27.63M	17.18%23.46M
Cost of revenue	18.64%65.11M	-21.72%9.89M	23.72%18.21M	24.62%20.16M	48.43%16.85M	19.24%54.87M	15.41%12.63M	29.65%14.72M	11.38%16.18M	23.33%11.36M
Gross profit	17.31%61.94M	39.92%24.35M	11.71%13.23M	1.30%11.6M	5.45%12.76M	30.93%52.8M	79.13%17.4M	-0.33%11.84M	44.62%11.46M	11.94%12.1M
Operating expense	-24.14%172.55M	-8.44%34.57M	-28.98%38.16M	-11.40%54.01M	-38.92%45.82M	-11.89%227.46M	-40.31%37.76M	-15.51%53.72M	-10.87%60.95M	19.23%75.03M
Selling and administrative expenses	-2.75%116.66M	-11.54%23.62M	-12.71%24.6M	13.44%36.44M	-2.88%32.01M	-5.80%119.95M	-22.33%26.7M	-19.48%28.18M	-3.13%32.12M	32.83%32.96M
-Selling and marketing expense	-18.02%67.64M	-30.64%12.33M	-29.50%12.96M	-7.56%21.21M	-9.68%21.15M	-5.35%82.51M	-27.41%17.78M	-27.09%18.38M	3.09%22.94M	53.73%23.42M
-General and administrative expense	30.92%49.01M	26.51%11.29M	18.80%11.64M	65.89%15.23M	13.85%10.85M	-6.76%37.44M	-9.74%8.92M	0.13%9.8M	-15.82%9.18M	-0.42%9.53M
Research and development costs	-48.01%55.9M	-0.97%10.95M	-46.93%13.56M	-39.06%17.57M	-67.16%13.82M	-17.82%107.51M	-61.71%11.06M	-10.67%25.55M	-18.16%28.83M	10.37%42.07M
Operating profit	36.67%-110.62M	49.79%-10.22M	40.48%-24.93M	14.33%-42.4M	47.45%-33.06M	19.82%-174.66M	61.98%-20.36M	19.00%-41.88M	18.14%-49.5M	-20.74%-62.92M
Net non-operating interest income expense	39.71%-504K					57.71%-836K
Non-operating interest income	105.37%3.36M	----	----	----	----	278.29%1.64M	----	----	----	----
Non-operating interest expense	56.35%3.87M	----	----	----	----	2.66%2.47M	----	----	----	----
Other net income (expense)	108.58%560K	0	-203.85%-79K	105.01%344K	130.57%295K	-643.74%-6.53M	52.30%1.32M	96.29%-26K	-1,156.59%-6.86M	-93.00%-965K
Other non- operating income (expenses)	108.58%560K	--0	-203.85%-79K	105.01%344K	130.57%295K	-643.74%-6.53M	52.30%1.32M	96.29%-26K	-1,156.59%-6.86M	-93.00%-965K
Income before tax	39.26%-110.56M	46.03%-10.72M	40.33%-25.01M	25.37%-42.06M	48.71%-32.77M	17.52%-182.02M	63.64%-19.87M	20.04%-41.91M	7.63%-56.36M	-21.43%-63.89M
Income tax
Net income	39.26%-110.56M	46.03%-10.72M	40.33%-25.01M	25.37%-42.06M	48.71%-32.77M	17.52%-182.02M	63.64%-19.87M	20.04%-41.91M	7.63%-56.36M	-21.43%-63.89M
Net income continuous Operations	39.26%-110.56M	46.03%-10.72M	40.33%-25.01M	25.37%-42.06M	48.71%-32.77M	17.52%-182.02M	63.64%-19.87M	20.04%-41.91M	7.63%-56.36M	-21.43%-63.89M
Minority interest income
Net income attributable to the parent company	39.26%-110.56M	46.03%-10.72M	40.33%-25.01M	25.37%-42.06M	48.71%-32.77M	17.52%-182.02M	63.64%-19.87M	20.04%-41.91M	7.63%-56.36M	-21.43%-63.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	39.26%-110.56M	46.03%-10.72M	40.33%-25.01M	25.37%-42.06M	48.71%-32.77M	17.52%-182.02M	63.64%-19.87M	20.04%-41.91M	7.63%-56.36M	-21.43%-63.89M
Basic earnings per share	52.10%-0.8	70.59%-0.05	55.26%-0.17	36.36%-0.35	57.14%-0.27	25.45%-1.67	68.52%-0.17	25.49%-0.38	11.29%-0.55	-8.62%-0.63
Diluted earnings per share	52.10%-0.8	70.59%-0.05	55.26%-0.17	36.36%-0.35	57.14%-0.27	25.45%-1.67	68.52%-0.17	25.49%-0.38	11.29%-0.55	-8.62%-0.63
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall